Drug
Hyperpolarized 129xenon Gas
Hyperpolarized 129xenon Gas: highest development phase Phase 2, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Hyperpolarized 129Xenon gas NCT03367312 | Phase 2 | Pulmonary Vascular Disease |
Latest
No recent events.
Follow Hyperpolarized 129xenon Gas on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.